BIOYF Stock News 4.8690 05/07/2014 14:56:24 Biosyent Inc (BI

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Biosyent Inc (BIOYF) 4.8690 $BIOYF

BioSyent Releases Q4 and Full Year 2013 Results: Full Year Sales Increase 55%, Net Income Up 25%, 3 Year CAGR 67%, Q4 Sales Increase 61%
Marketwire - Wed Mar 12, 7:02AM CDT
BioSyent Inc. ("BioSyent" (TSX VENTURE: RX) released today a summary of its Fiscal 2013 and Fourth Quarter (Q4 2013) financial results. Key highlights include:

BioSyent Pharma Signs Exclusive Licence and Distribution Agreement for a New Gastrointestinal Health Product Already Approved by Health Canada-2014 Launch Planned
Marketwire - Tue Mar 04, 7:03AM CST
BioSyent Inc. (TSX VENTURE: RX) ("BioSyent" is pleased to announce that its subsidiary BioSyent Pharma Inc. has signed an exclusive Canadian Licence and Distribution Agreement with an existing European partner for a gastrointestinal health product that has already been approved by Health Canada.

Heavy Rains Threaten Household Food Security
by Tendayi Nyahuye and Farai Rugeje - All Africa Global Media - Fri Feb 14, 2:05AM CST
Heavy rains received this month have impacted negatively on the food security of households after destroying crops in most parts of the country. Floods have been experienced in low-lying areas like Chivi, Masvingo and Tsholotsho, but the worst hit is the Tokwe-Mukosi area where the water in the dam has risen to dangerous levels.

BioSyent Named to the 2014 TSX Venture Top 50(R) Ranking-Only TSX Venture Company to Be Recognized as a Top Performer for the Past 3 Consecutive Years
Marketwire - Thu Feb 13, 7:01AM CST
BioSyent Inc. ("BioSyent" (TSX VENTURE: RX) announced today that it has again been named as one of the TSX Venture Top 50 companies.

North American Palladium Reports Positive Production Ramp Up Progress
Marketwire Canada - Wed Feb 12, 4:03PM CST
All figures are in Canadian dollars except where noted.

BioSyent Announces Appointment of New Director
Marketwire - Thu Jan 16, 7:02AM CST
The Board of Directors of BioSyent Inc. ("BioSyent" (TSX VENTURE: RX) is pleased to announce the appointment of Stephen Wilton to the Company's Board.

BioSyent to Present at the LD Micro VI Investor Conference
Marketwire - Mon Dec 02, 7:02AM CST
BioSyent Inc. ("BioSyent" (TSX VENTURE: RX) is pleased to announce that CEO Rene Goehrum will be making a presentation at the LD Micro VI Investor Conference at 9am (PT), December 4, 2013 at the Luxe Sunset Boulevard Hotel in Los Angeles, CA. Mr. Goehrum will provide an overview of the Company and its corporate activities.

BioSyent Releases Q3 and Nine Month Results-Nine Month Sales Increase 53% and Profit Before Tax Up 77%
Marketwire - Thu Nov 21, 5:01AM CST
BioSyent Inc. ("BioSyent" (TSX VENTURE: RX) released today a summary of its financial results for the three months (Q3) and nine months ending September 30, 2013.

BioSyent Releases Q2 and Six Month Results: Six Month Sales Increase 57% and Profit Before Tax Up 68%
Marketwire - Thu Aug 22, 7:02AM CDT
BioSyent Inc. ("BioSyent" (TSX VENTURE: RX) released today a summary of its second quarter (Q2) and first half (H1) 2013 financial results for the three and six months ending June 30, 2013.

BioSyent Pharma Launches New FeraMAX(R) Powder-Water Soluble Polysaccharide-Iron Complex Iron Supplement
Marketwire Canada - Thu Jun 06, 7:00AM CDT
BioSyent Inc. ("BioSyent"(TSX VENTURE:RX) today announced that its subsidiary BioSyent Pharma Inc. has commenced the Canadian launch of its unique new oral iron supplement - FeraMAX(R) Powder.

BioSyent Named to the PROFIT 500 Ranking of Canada's Fastest-Growing Companies with a 5 Year Revenue Growth Rate of 355%
Marketwire - Tue Jun 04, 7:03AM CDT
BioSyent Inc. (TSX VENTURE: RX) ("BioSyent" is pleased to announce that PROFIT Magazine has ranked BioSyent as one of Canada's Fastest-Growing Companies in the just released 2013 rankings. Published in the Summer issue of PROFIT Magazine and online at PROFITguide.com, the PROFIT 500 ranks Canadian businesses by their revenue growth over five years. Based upon a five year revenue (2007-2012) growth rate of 355%, BioSyent ranked #183 on the PROFIT 500 list.

BioSyent Pharma Submits Two New Drugs to Health Canada for Marketing Approval
Marketwire - Thu May 23, 7:02AM CDT
BioSyent Inc. (TSX VENTURE: RX) ("BioSyent" is pleased to announce that its subsidiary, BioSyent Pharma Inc., has submitted two new drug products to Health Canada seeking marketing approval.
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Vitamin Angels Drives Global Nutrition Advancements

Updated Category News Views 9

Navigating the Waters of Global Nutrition Bet you never thought a vitamin program could spearhead the front lines of healthcare, huh? Vitamin Angels are grinding away under the radar, shifting the landscape for maternal and child nutrition. At the heart of it all is their vision to make UNIMMAP multiple micronutrient supplementation (MMS) a staple in the global playbook....

Continue Reading
Gong, Agentforce, Avoma Crowned 2026 CI Champions

Updated Category News Views 9

Diving Deep into Conversation Intelligence There's a lot to unpack when three software titans hog the spotlight, and that's exactly what's happening in the world of conversation intelligence this year. It's like we've hit the jackpot with Gong, Agentforce Sales, and Avoma carving out their turf as the 2026 Champions, according to the venerable Info-Tech Research Group....

Continue Reading
OCI N.V. Secures a Win in Court; EGM Proceeds as Planned

Updated Category News Views 13

OCI Dodges a Bullet in Amsterdam Court Stepping into the courtroom drama, OCI N.V. just took home a win as the Amsterdam Court of Appeal's Enterprise Chamber gave them a clean bill of health, kicking out the inquiry request from VEB and a bunch of other shareholders. The judges weren't convinced there was anything fishy going on, so they tossed the inquiry petition and...

Continue Reading
Wally Disrupts Dental Industry with $25M Funding

Updated Category News Views 12

A New Breath of Fresh Air for Dental Care Dental visits—a tedious, costly affair we've all dreaded. So, when Wally rolls out an overhaul in this stale landscape, it's worth taking notice. With $25 million in their pockets from Series A funding led by Maveron, Wally's swaggering in with a plan to flip the script on dental care across the nation. Redefining the Dental...

Continue Reading
HelloNation Brings 'Edvertising' to NC REALTORS® Event

Updated Category News Views 13

HelloNation's Bold Step into Real Estate Networking October 8th to the 11th is shaping up to be a pivotal few days in Wilmington, North Carolina. Here’s the scoop: HelloNation, known for its innovative 'edvertising' model, is joining the bustling crowd at the 2026 NC REALTORS® Convention. This isn’t just any get-together—it's the grandest annual jamboree for real...

Continue Reading
Duke Energy's Cost-Protection Plan Shields Ratepayers

Updated Category News Views 8

Shielding Customers From Data Center Costs Let's get right into the thick of it: Duke Energy's latest move is a strategic one, shrouded in industry terms but with a real impact on regular folks' wallets. The company's agreement with heavyweights like Amazon, Google, and Meta aims to protect existing customers in North Carolina from getting hit with the costs of powering...

Continue Reading
Merit Expands in New York with Bold Acquisition Move

Updated Category News Views 11

Merit Financial's Growth Trajectory Takes a Leap You watch the movers and shakers in this game long enough, and you start to see patterns. Merit Financial Advisors is one of those juggernauts you'd better keep an eye on. These folks just scooped up Moldenhauer & Associates—a firm that's been a staple in Orchard Park, New York—for a cool $1.1 billion worth of client...

Continue Reading
Decoding CarBravo-Certified vs Traditional Used Cars

Updated Category News Views 7

What’s Behind Door Number One: CarBravo Certification When you walk onto a car lot these days, it's a mixed bag: shiny badges boasting certifications or basic used car signage. For anyone who's spent time around cars, two types stick out—there’s your CarBravo-certified vehicles and your good ol' used cars. Now, Marissa McCoy and Jill Maniaci from Heidebreicht...

Continue Reading
C3EL Expands Federal Footprint with Strategic Contracts

Updated Category News Views 5

Pushing Boundaries in Federal Contracts What a ride C3EL's had in Government Fiscal Year 2026! Let me tell you, they’ve bagged a bunch of contracts that’d make any company’s mouth water. Kicking things off, they snagged a prime cybersecurity contract from the U.S. Air Force. Considering our current cybersecurity landscape, that's like striking gold. But they...

Continue Reading
Ornellaia's 2026 Harvest: Adapting to Nature's Whims

Updated Category News Views 7

A Year Marked by Weather's Unpredictable Dance Nobody said making wine was a walk in the park, and the folks at Ornellaia know better than most how to roll with whatever nature throws their way. The 2026 harvest story is as much about unlocking the secrets of the soil as it is about navigating the quirks of the weather. Situated in Bolgheri, Italy, this year's vintage...

Continue Reading

Top 5 Most Recently Viewed Articles

Conavi Medical Highlights Growth Potential and Financial Updates

Updated Category News Views 110

Conavi Medical's Financial Progress and Strategic Updates Conavi Medical Corp. (TSXV: CNVI) (OTCQB: CNVIF) has recently completed an impressive upsized financing of $20 million. This funding, primarily driven by U.S. institutional investors, is anticipated to play a crucial role in advancing the company towards the commercial launch of its next-generation Novasight...

Continue Reading
Understanding the Recent Dealing Disclosure by Treatt plc

Updated Category News Views 170

Recent Dealings by Treatt plc and Their Implications Treatt plc has recently come under the spotlight due to its activities in share dealing, marked by a valuable update that reflects the company's engagement in the financial markets. These disclosures are not just formalities; they provide investors with insights into the ongoing operational dynamics of the company and...

Continue Reading
Ellomay Capital's Growth in Italian Solar Energy Initiatives

Updated Category News Views 130

Ellomay Capital's Expansion in Italian Solar Energy Ellomay Capital Ltd. (NYSE American; TASE: ELLO), a prominent player in the renewable energy sector, has made significant strides with its solar projects in Italy. The company recently announced the achievement of a critical milestone with the successful award of the FER X Tender for its 79.5 MW solar project, "Ellomay...

Continue Reading
AIME Marks Successful Seventh Annual Fuse National Conference

Updated Category News Views 162

AIME Celebrates Success at the Seventh Annual Fuse National Conference Recently, the Association of Independent Mortgage Experts (AIME) marked an important milestone with its seventh annual Fuse National Conference, which took place in lively New Orleans, moving away from its traditional Las Vegas location for the first time. In spite of recent hurdles, including...

Continue Reading
Finnovate Acquisition Corp. Updates Monthly Sponsor Contributions

Updated Category News Views 75

Finnovate Acquisition Corp. Updates on Sponsor Contributions Finnovate Acquisition Corp. (Nasdaq: FNVT, FNVTU, FNVTW) has made an important announcement regarding its upcoming extraordinary general meeting of shareholders. The company is proposing an extension of time to facilitate its initial business combination. In light of this, the Finnovate Sponsor, L.P. is revising...

Continue Reading